Close Menu

Now that Pfizer's acquisition of Wyeth is complete, the cuts are coming -- this week, the pharma announced that it would shut down six of its 20 research facilities (with some question marks hanging over others). "Pfizer didn't say how many R&D jobs it would cut or how much it hoped to save from the shutdowns," according to this news analysis story from the Wall Street Journal.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.